No Data
No Data
No Data
Express News | Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024
ReutersMay 1 08:00 ET
How Is The Market Feeling About Marinus Pharma?
Marinus Pharma's (NYSE:MRNS) short percent of float has fallen 3.64% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 6.35% of all regular shar
BenzingaApr 29 10:45 ET
Market Cool On Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Revenues Pushing Shares 84% Lower
The Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) share price has fared very poorly over the last month, falling by a substantial 84%. For any long-term shareholders, the last month ends a year to fo
Simply Wall StApr 25 07:33 ET
Express News | Tang Capital Partners LP Reports 8.2% Passive Stake in Marinus Pharmaceuticals Inc as of April 16 - SEC Filing
Moomoo 24/7Apr 19 06:12 ET
Marinus Pharmaceuticals Is Maintained at Buy by Truist Securities
Marinus Pharmaceuticals Is Maintained at Buy by Truist Securities
Dow JonesApr 18 07:24 ET
Express News | Marinus Pharmaceuticals Inc : Truist Securities Cuts Target Price to $10 From $25: Truist Securities Cuts Target Price to $10 From $25
Moomoo 24/7Apr 18 06:55 ET